DK153918C - Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater - Google Patents

Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater

Info

Publication number
DK153918C
DK153918C DK205376A DK205376A DK153918C DK 153918 C DK153918 C DK 153918C DK 205376 A DK205376 A DK 205376A DK 205376 A DK205376 A DK 205376A DK 153918 C DK153918 C DK 153918C
Authority
DK
Denmark
Prior art keywords
tablets
procedure
preparation
water soluble
high content
Prior art date
Application number
DK205376A
Other languages
English (en)
Other versions
DK153918B (da
DK205376A (da
Inventor
Klaus Gleixner
Roland Mueller
Franz Lehrach
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK205376A publication Critical patent/DK205376A/da
Publication of DK153918B publication Critical patent/DK153918B/da
Application granted granted Critical
Publication of DK153918C publication Critical patent/DK153918C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK205376A 1975-05-10 1976-05-07 Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater DK153918C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2520978A DE2520978C3 (de) 1975-05-10 1975-05-10 Dosierungseinheit einer festen, oral zu verabreichenden Arzneiform von wasserlöslichen Xanthin-Derivaten
DE2520978 1975-05-10

Publications (3)

Publication Number Publication Date
DK205376A DK205376A (da) 1976-11-11
DK153918B DK153918B (da) 1988-09-26
DK153918C true DK153918C (da) 1989-02-06

Family

ID=5946306

Family Applications (1)

Application Number Title Priority Date Filing Date
DK205376A DK153918C (da) 1975-05-10 1976-05-07 Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater

Country Status (12)

Country Link
US (1) US4189469A (da)
AU (1) AU502644B2 (da)
BE (1) BE841617A (da)
CY (1) CY1153A (da)
DE (1) DE2520978C3 (da)
DK (1) DK153918C (da)
FR (1) FR2310764A1 (da)
GB (1) GB1547232A (da)
HK (1) HK42382A (da)
KE (1) KE3219A (da)
MY (1) MY8600617A (da)
ZA (1) ZA762748B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491539A (en) * 1981-06-04 1985-01-01 The Procter & Gamble Company Liquid cleansing product with skin feel additives
DE3127237A1 (de) * 1981-07-10 1983-01-20 Hoechst Ag, 6000 Frankfurt Magenvertraegliche arzneiformen von xanthinderivaten und verfahren zu ihrer herstellung
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
DE3508097A1 (de) * 1984-07-21 1986-02-06 Hoechst Ag, 6230 Frankfurt Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung
WO1986006627A1 (en) * 1985-05-15 1986-11-20 Riker Laboratories, Inc. Sustained release theophylline compositions and processes
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
US4820522A (en) * 1987-07-27 1989-04-11 Mcneilab, Inc. Oral sustained release acetaminophen formulation and process
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5112827A (en) * 1990-05-18 1992-05-12 Board Of Regents, The University Of Texas System Drug to reverse fatty liver and atheromatous lesions
FR2677886B1 (fr) * 1991-06-18 1995-03-31 Adir Comprime matriciel permettant la liberation prolongee d'indapamide apres administration par voie orale.
US5498802A (en) * 1995-02-28 1996-03-12 Hoechst Celanese Corporation Process for preparing omega-halo-ketones
US20040209900A1 (en) * 2003-04-15 2004-10-21 Hauptman Stephen P. Treatment of lipodystrophy (lipid redistribution syndrome)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1617418C3 (de) * 1967-12-16 1980-01-24 Hoechst Ag, 6000 Frankfurt Herstellung von festen Arzneimittelformen mit verzögerter Wirkstoffabgabe
US3577514A (en) * 1968-06-10 1971-05-04 Pfizer Sustained release pharmaceutical tablets
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3639169A (en) * 1969-04-29 1972-02-01 Sucrest Corp Direct compression vehicles and method therefor

Also Published As

Publication number Publication date
AU1376576A (en) 1977-11-17
GB1547232A (en) 1979-06-06
CY1153A (en) 1982-09-10
MY8600617A (en) 1986-12-31
KE3219A (en) 1982-08-13
HK42382A (en) 1982-10-08
DE2520978B2 (de) 1980-06-12
US4189469A (en) 1980-02-19
DE2520978C3 (de) 1981-02-19
DE2520978A1 (de) 1976-11-18
DK153918B (da) 1988-09-26
ZA762748B (en) 1977-04-27
DK205376A (da) 1976-11-11
AU502644B2 (en) 1979-08-02
FR2310764B1 (da) 1980-07-11
FR2310764A1 (fr) 1976-12-10
BE841617A (fr) 1976-11-08

Similar Documents

Publication Publication Date Title
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK235876A (da) Fremgangsmade til fremstilling af thienopyridinderivater
DK138749C (da) Analogifremgangsmaade til fremstilling af 18-methyl-4,15-oestradiener
DK153918C (da) Fremgangsmaade til fremstilling af oralt indgivelige tabletter, der hver har hoejt indhold af vandoploeselige xanthinderivater
DK68976A (da) Fremgangsmade til fremstilling af enolderivater
DK344076A (da) Fremgangsmade til fremstilling af thienopyridinderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK139267B (da) Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK135040B (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridiner
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK410876A (da) Fremgangsmade til fremstilling af hydrogenerede 1-oxo-isoindolin-derivater
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
AR211854A1 (es) Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina
DK141532C (da) Fremgangsmaade til fremstilling af 21-hydroxy-16-pregnen-20-onderivater
DK275278A (da) Fremgangsmaade til fremstilling af indolinderivater
DK562076A (da) Fremgangsmade til fremstilling af azetidinonderivater
DK62876A (da) Fremgangsmade til fremstilling af benzo-cyclohepta-thiophenderivater
DK305076A (da) Fremgangsmade til fremstilling af d,l-pantolacton
DK139269B (da) Fremgangsmaade til fremstilling af 4-androsten3,17-dionderivatier
DK136653B (da) Fremgangsmåde til fremstilling af thieno-pyridinderivater.

Legal Events

Date Code Title Description
PUP Patent expired